A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology-Reference-Cited by-同舟云学术

A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncology

Published:2020-09 Issue:3 Volume:158 Page:794-802
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Chambers Laura M.,Costales Anthony B.,Crean-Tate Katie,Kuznicki Michelle,Morton Molly,Horowitz Max,Jagielo Tiffany,Rose Peter G.,Michener Chad,Vargas Roberto,Debernardo Robert

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference65 articles.

1. Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery;Bae;Gynecol.Oncol.,2007

2. Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC/IV ovarian cancer;Cascales-Campos;Ann.Surg.Oncol.,2014

3. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer;van Driel;N.Engl.J.Med.,2018

4. Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: A French multicentre retrospective cohort study of 566 patients

5. Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases;Di Giorgio;Ann.Surg.Oncol.,2017

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of Paclitaxel-based hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer patients - interim analysis of safety and immediate efficacy of a randomized control trial (C-HOC trial);Journal of Ovarian Research;2024-07-12

2. Determining the maximum tolerated dose of paclitaxel combined with fixed dose of cisplatin for hyperthermic intraperitoneal chemotherapy in ovarian cancer: A multicenter phase I trial;Gynecologic Oncology;2024-02

3. Intraperitoneal and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Ovarian Cancer;Current Treatment Options in Oncology;2024-01-04

4. A phase I dose-finding trial of hyperthermic intraperitoneal docetaxel combined with cisplatin in patients with advanced-stage ovarian cancer;Journal of Gynecologic Oncology;2024

5. Is routine admission to a critical care setting following hyperthermic intraperitoneal chemotherapy for ovarian cancer necessary?;European Journal of Surgical Oncology;2023-12